Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of molecular medicine, 2014 - Springer
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of Molecular Medicine, 2014 - infona.pl
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of Molecular Medicine, 2014 - search.proquest.com
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.
A Gower, Y Wang, G Giaccone - Journal of Molecular Medicine …, 2014 - europepmc.org
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
[引用][C] Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of Molecular Medicine, 2014 - cir.nii.ac.jp
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of molecular …, 2014 - pubmed.ncbi.nlm.nih.gov
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
[HTML][HTML] Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
A Gower, Y Wang, G Giaccone - Journal of molecular medicine …, 2014 - ncbi.nlm.nih.gov
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.
A Gower, Y Wang, G Giaccone - Journal of Molecular …, 2014 - search.ebscohost.com
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.
A Gower, Y Wang, G Giaccone - Journal of Molecular Medicine …, 2014 - europepmc.org
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …
molecular profiling has dramatically changed the way advanced adenocarcinoma is treated …